Literature DB >> 23650208

LC/MS characterization of rotenone induced cardiolipin oxidation in human lymphocytes: implications for mitochondrial dysfunction associated with Parkinson's disease.

Yulia Y Tyurina1, Daniel E Winnica, Valentina I Kapralova, Alexandr A Kapralov, Vladimir A Tyurin, Valerian E Kagan.   

Abstract

SCOPE: Rotenone is a toxicant believed to contribute to the development of Parkinson's disease. METHODS AND
RESULTS: Using human peripheral blood lymphocytes we demonstrated that exposure to rotenone resulted in disruption of electron transport accompanied by the production of reactive oxygen species, development of apoptosis and elevation of peroxidase activity of mitochondria. Employing LC/MS-based lipidomics/oxidative lipidomics we characterized molecular species of cardiolipin (CL) and its oxidation/hydrolysis products formed early in apoptosis and associated with the rotenone-induced mitochondrial dysfunction.
CONCLUSION: The major oxidized CL species - tetra-linoleoyl-CL - underwent oxidation to yield epoxy-C18:2 and dihydroxy-C18:2 derivatives predominantly localized in sn-1 and sn-2 positions, respectively. In addition, accumulation of mono-lyso-CL species and oxygenated free C18:2 were detected in rotenone-treated lymphocytes. These oxidation/hydrolysis products may be useful for the development of new biomarkers of mitochondrial dysfunction.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Apoptosis; Cardiolipin peroxidation; Lymphocytes; Mitochondrial dysfunction; Parkinson's disease biomarkers

Mesh:

Substances:

Year:  2013        PMID: 23650208      PMCID: PMC3810210          DOI: 10.1002/mnfr.201200801

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  78 in total

Review 1.  Apoptosis signaling pathways and lymphocyte homeostasis.

Authors:  Guangwu Xu; Yufang Shi
Journal:  Cell Res       Date:  2007-09       Impact factor: 25.617

Review 2.  Parkinson's disease.

Authors:  Bobby Thomas; M Flint Beal
Journal:  Hum Mol Genet       Date:  2007-10-15       Impact factor: 6.150

Review 3.  Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease.

Authors:  Derek A Drechsel; Manisha Patel
Journal:  Free Radic Biol Med       Date:  2008-03-04       Impact factor: 7.376

4.  Cardiolipin as an oxidative target in cardiac mitochondria in the aged rat.

Authors:  Edward J Lesnefsky; Charles L Hoppel
Journal:  Biochim Biophys Acta       Date:  2008-06-02

Review 5.  Mitochondrial dysfunction in Parkinson's disease.

Authors:  Jiro Fukae; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Mitochondrion       Date:  2006-12-13       Impact factor: 4.160

6.  Oxidative lipidomics of gamma-irradiation-induced intestinal injury.

Authors:  Yulia Y Tyurina; Vladimir A Tyurin; Michael W Epperly; Joel S Greenberger; Valerian E Kagan
Journal:  Free Radic Biol Med       Date:  2007-09-06       Impact factor: 7.376

7.  Diagnosis of Barth syndrome using a novel LC-MS/MS method for leukocyte cardiolipin analysis.

Authors:  Ann Bowron; Robert Frost; Vicki E C Powers; Paul H Thomas; Simon J R Heales; Colin G Steward
Journal:  J Inherit Metab Dis       Date:  2012-10-30       Impact factor: 4.982

8.  A simplified and reliable assay for complex I in human blood lymphocytes.

Authors:  L E A de Wit; L Spruijt; G C Schoonderwoerd; I F M de Coo; H J M Smeets; H R Scholte; W Sluiter
Journal:  J Immunol Methods       Date:  2007-08-01       Impact factor: 2.303

9.  Cardiolipin deficiency leads to decreased cardiolipin peroxidation and increased resistance of cells to apoptosis.

Authors:  Zhentai Huang; Jianfei Jiang; Vladimir A Tyurin; Qing Zhao; Alexandra Mnuskin; Jin Ren; Natalia A Belikova; Weihong Feng; Igor V Kurnikov; Valerian E Kagan
Journal:  Free Radic Biol Med       Date:  2008-03-13       Impact factor: 7.376

10.  Selective early cardiolipin peroxidation after traumatic brain injury: an oxidative lipidomics analysis.

Authors:  Hülya Bayir; Vladimir A Tyurin; Yulia Y Tyurina; Rosa Viner; Vladimir Ritov; Andrew A Amoscato; Qing Zhao; Xiaojing J Zhang; Keri L Janesko-Feldman; Henry Alexander; Liana V Basova; Robert S B Clark; Patrick M Kochanek; Valerian E Kagan
Journal:  Ann Neurol       Date:  2007-08       Impact factor: 10.422

View more
  19 in total

1.  Mitochondrial Redox Opto-Lipidomics Reveals Mono-Oxygenated Cardiolipins as Pro-Apoptotic Death Signals.

Authors:  Gaowei Mao; Feng Qu; Claudette M St Croix; Yulia Y Tyurina; Joan Planas-Iglesias; Jianfei Jiang; Zhentai Huang; Andrew A Amoscato; Vladimir A Tyurin; Alexandr A Kapralov; Amin Cheikhi; John Maguire; Judith Klein-Seetharaman; Hülya Bayır; Valerian E Kagan
Journal:  ACS Chem Biol       Date:  2016-01-05       Impact factor: 5.100

Review 2.  First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics.

Authors:  Hazel H Szeto
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

3.  Effects of cardiolipin on membrane morphology: a Langmuir monolayer study.

Authors:  Minh Dinh Phan; Kwanwoo Shin
Journal:  Biophys J       Date:  2015-04-21       Impact factor: 4.033

4.  Comparing phospholipid profiles of mitochondria and whole tissue: Higher PUFA content in mitochondria is driven by increased phosphatidylcholine unsaturation.

Authors:  Cyrus E Kuschner; Jaewoo Choi; Tai Yin; Koichiro Shinozaki; Lance B Becker; Joshua W Lampe; Junhwan Kim
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2018-07-10       Impact factor: 3.205

Review 5.  Known unknowns of cardiolipin signaling: The best is yet to come.

Authors:  John J Maguire; Yulia Y Tyurina; Dariush Mohammadyani; Aleksandr A Kapralov; Tamil S Anthonymuthu; Feng Qu; Andrew A Amoscato; Louis J Sparvero; Vladimir A Tyurin; Joan Planas-Iglesias; Rong-Rong He; Judith Klein-Seetharaman; Hülya Bayır; Valerian E Kagan
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-08-04       Impact factor: 4.698

Review 6.  Characterization of cardiolipins and their oxidation products by LC-MS analysis.

Authors:  Yulia Y Tyurina; Rosario M Domingues; Vladimir A Tyurin; Elisabete Maciel; Pedro Domingues; Andrew A Amoscato; Hülya Bayir; Valerian E Kagan
Journal:  Chem Phys Lipids       Date:  2013-12-12       Impact factor: 3.329

7.  Cardiolipin-induced activation of pyruvate dehydrogenase links mitochondrial lipid biosynthesis to TCA cycle function.

Authors:  Yiran Li; Wenjia Lou; Vaishnavi Raja; Simone Denis; Wenxi Yu; Michael W Schmidtke; Christian A Reynolds; Michael Schlame; Riekelt H Houtkooper; Miriam L Greenberg
Journal:  J Biol Chem       Date:  2019-06-11       Impact factor: 5.157

8.  LC/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: Implication for mitochondrial dysfunction in Parkinson's disease.

Authors:  Y Y Tyurina; A M Polimova; E Maciel; V A Tyurin; V I Kapralova; D E Winnica; A S Vikulina; M R M Domingues; J McCoy; L H Sanders; H Bayır; J T Greenamyre; V E Kagan
Journal:  Free Radic Res       Date:  2015-03-05

9.  Distinct membrane properties are differentially influenced by cardiolipin content and acyl chain composition in biomimetic membranes.

Authors:  Edward Ross Pennington; Amy Fix; E Madison Sullivan; David A Brown; Anthony Kennedy; Saame Raza Shaikh
Journal:  Biochim Biophys Acta Biomembr       Date:  2016-11-24       Impact factor: 3.747

10.  Alteration of cardiolipin biosynthesis and remodeling in single right ventricle congenital heart disease.

Authors:  Anastacia M Garcia; Jessica C McPhaul; Genevieve C Sparagna; Danielle A Jeffrey; Raleigh Jonscher; Sonali S Patel; Carmen C Sucharov; Brian L Stauffer; Shelley D Miyamoto; Kathryn C Chatfield
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-14       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.